Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,817 | 12,821 | 24,490 | 19,330 | 33,310 |
| Marketable Securities | 1,615 | 1,841 | 1,940 | 1,970 | 1,960 |
| Receivables | 266 | 174 | 100 | 40 | 50 |
| Other current assets | 0 | 0 | 360 | 340 | 740 |
| TOTAL | $21,095 | $15,099 | $26,890 | $21,680 | $36,060 |
| Non-Current Assets | |||||
| PPE Net | 360 | 476 | 510 | 400 | 390 |
| TOTAL | $360 | $476 | $510 | $400 | $390 |
| Total Assets | $21,455 | $15,575 | $27,410 | $22,090 | $36,450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,123 | 3,057 | 5,830 | 7,290 | 6,580 |
| TOTAL | $2,123 | $3,057 | $5,830 | $7,290 | $6,580 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,123 | $3,057 | $5,830 | $7,290 | $6,580 |
| Shareholders' Equity | |||||
| Common Shares | 204,748 | 215,294 | 222,070 | 198,270 | 179,410 |
| Retained earnings | -206,601 | -226,445 | -224,730 | -207,930 | -173,490 |
| Other shareholders' equity | 596 | 254 | 440 | 310 | 2,560 |
| TOTAL | $19,332 | $12,519 | $21,570 | $14,790 | $29,870 |
| Total Liabilities And Equity | $21,455 | $15,575 | $27,400 | $22,080 | $36,450 |